{
    "type": "ETF",
    "ucits": true,
    "replication_method": "physical",
    "leverage": false,
    "derivatives": false,
    "swaps": false,
    "inverse": false,
    "complex_factors": [
        "Emerging market bonds",
        "ESG screening methodology",
        "Potential illiquidity in bond markets"
    ],
    "classification": "non-complex",
    "supporting_data": "The L&G ESG Emerging Markets Corporate Bond (USD) UCITS ETF is classified as non-complex under MiFID II based on the following analysis: 1. Replication Method: The fund uses physical replication with optimised sampling, which is a straightforward approach. 2. Derivative Usage: While the KIID mentions the potential use of financial derivative instruments (FDIs), these are not central to the investment strategy and appear to be used for efficient portfolio management rather than for leverage or complex strategies. 3. Leverage and Inverse Exposure: There is no mention of leverage, inverse exposure, or amplified returns in the documentation. 4. Underlying Assets: The fund invests in emerging market corporate bonds, which are inherently riskier but not inherently complex. The ESG screening methodology adds a layer of complexity but does not make the fund complex under MiFID II. 5. Risk Profile: The fund is rated 4 out of 7 on the risk scale, indicating moderate risk but not extreme complexity. 6. Key Risks: The main risks are related to emerging market exposure, bond market illiquidity, and counterparty risk, but these are typical for bond funds and do not indicate complexity. 7. Costs and Charges: The fee structure is simple and transparent, with an ongoing charge of 0.35%. The PRIIPs KID and factsheet do not introduce any additional complexity factors. The fund is UCITS compliant, which typically indicates a non-complex structure suitable for retail investors. The main potential complexity factors are the emerging market focus and the ESG screening methodology, but these do not meet the MiFID II criteria for complexity. The fund's use of derivatives is minimal and does not appear to be a significant factor in its risk profile.",
    "confidence": 90
}